Eugene Kim, MD, has been named surgeon-in-chief and associate director of surgery at Torrance, Calif.-based Cedars-Sinai Guerin Children's.

A University of California Irvine study reported 90% patient satisfaction in cancer patients who were offered a multilanguage electronic tool to report their symptoms.

A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma. 

The FDA has given fast-track designation to Diakonos Oncology for its pancreatic cancer vaccine.

Tampa (Fla.) General Hospital has received a "substantial" gift to develop a center of colorectal cancer excellence. 

The median compensation for hematologists and medical oncologists increased 7.1% from 2023 to 2024, going from $498,062 to $533,402, according to the American Medical Group Association.

A University of Cambridge poll found 70% of people fear a late cancer diagnosis.

Cancer Resource Center of the Finger Lakes has affiliated with Ithaca, N.Y.-based Cayuga Health System, effective July 1. 

Carilion Clinic in Roanoke, Va., received a $25 million gift to grow the health system's cancer program.

Among adults 30 and older, about 40% of cancer cases and nearly a half of all cancer deaths are linked to preventable risk factors, according to a new study from researchers at the American Cancer Society. 

Findings from a recent study challenge a push to reclassify low grade prostate cancer, Biopsy Gleason Grade Group 1, as "benign." 

A Boston-based Harvard Medical School study found oncologists unsure how to handle artificial intelligence if it presents a treatment plan they would not recommend.

CAR-T therapy is becoming a more frequent treatment for Medicare patients with diffuse large B-cell lymphoma, but changes in CAR-T treatments that push it as an earlier line of therapy may change where patients receive the therapy — and ultimately, its cost.

The blood pressure drug Losartan may be able to block a gene found in the blood, angiotensin II receptor type 1 (AGTR1), and improve the effectiveness of chemotherapy, according to a study published June 19 in Science Translational Medicine.

Cancer deaths are down over the past three decades, but cancerphobia is as strong as ever, Washington Post columnist Steven Petrow reported July 5.

The FDA has ordered Miami-based North Shore Medical Center to halt mammogram services over quality issues that may have led to inaccurate results, according to a letter obtained by the Miami Herald. 

Hannibal (Mo.) Regional Healthcare System has received $15 million in state funds to expand services and build a new cancer center in Kirksville, Mo., it announced July 2.

At The University of Texas MD Anderson Cancer Center, research and patient care are inextricably linked. Our approach to research-driven patient care involves using the latest clinical findings and advances to inform how we provide care and facilitate optimal patient outcomes. Patients play a vital role in this process, too. By engaging them throughout our studies, we unlock insights that drive the development of cutting-edge therapies, diagnostics, and breakthrough discoveries that bring us closer to fulfilling our mission to end cancer.  

Patients diagnosed with certain abdominal cancers at Charleston, S.C.-based MUSC Hollings Cancer Center can now get next-day access to follow-up care, the system announced July 2.

Researchers at Tampa-based University of South Florida and Bloomington-based Indiana University found cisplatin is linked to increased hearing loss.